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Abstract 
Fibromyalgia Syndrome (FM) has been defined as a "specific, chronic, 
non-degenerative, non-progressive, non-inflammatory, systemic pain condition." 
It is a syndrome, not a disease, since it is characterized by a specific set of signs 
and symptoms that occur together. It is currently estimated that seven to ten 
million Americans are affected by this syndrome. Because FM has few 
symptoms that are outwardly visible and almost every part of the body can be 
affected, it has been termed "the invisible disability" or the "irritable everything" 
syndrome. 
Because of the growing number of diagnosises being made and the wide 
spread physical abnormalities observed, FM has been studied extensively. 
Despite these many studies, no cause has been identified. However, these 
studies have provided insight into the complexity of this syndrome. There is now 
evidence for neuroendocrine abnormalities in Fibromyalgia patients as a result of 
the continued stress they encounter. These abnormalities seem to center around 
a dysfunction of negative feedback mechanisms within the hypothalamic-
pituitary-adrenal axis. Furthermore, it seems as though there may be a link 
between the high levels of stress and pain experienced by these patients. 
It is now being assumed that the solution to this syndrome may exist not in 
one single dysfunction, but rather in several abnormalities that feed off of each 
other to result in the symptoms of fibromyalgia. By examining these 
relationships, a clearer perspective may be obtained of the elusive cause of FM. 
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Introduction 
As diagnosises for Fibromyalgia (FM) continue to increase at a drastic 
rate, researchers have responded accordingly with over 1000 articles appearing 
in the last decade. The two most prominent areas of study attempting to explain 
this syndrome's origin have surrounded the issues of stress and pain. In this 
work, FM and the stress response system will be reviewed, and the existing 
research linking this response to FM will be presented and discussed. As the 
current research is presented, abnormalities in the neuroendocrine response to 
stress will become apparent. In addition to this, an attempt will be made to 
demonstrate the relationship between neuroendocrine abnormalities and 
persistent pain in fibromyalgia patients. Finally, a possible genetic predisposition 
for such abnormalities and ideas for future research on this syndrome will be 
explored. 
Fibromyalgia 
Fibromyalgia Syndrome, while first described by physicians in 1816, was 
not officially recognized by the American Medical Association as a true illness 
until 1987. It has been defined as a specific, chronic, non-degenerative, non-
progressive, non-inflammatory, systemic pain condition (1). Unlike a disease, 
which has known causes and understood mechanisms for producing symptoms, 
FM, which is of unknown etiology, has been characterized as a syndrome, or 
having a specific set of signs and symptoms that occur together. 
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Epidemiology 
It is estimated that anywhere from 3 to 10 million people are affected by 
FM, and it is the third most commonly diagnosed rheumatic disorder after 
osteoarthritis and rheumatoid arthritis (2, 3). It is seen in all races and age 
groups with the median onset of the syndrome occurring from 29 to 37 years (3). 
Unfortunately the median age of formal diagnosis for FM is 34 to 53 years, 
meaning that most patients endure symptoms for many years before they receive 
an accurate diagnosis (2). This usually occurs because fibromyalgia is frequently 
misdiagnosed and often confused with other disorders such as myofascial pain 
syndrome, hypothyroidism, rheumatoid arthritis, and chronic fatigue syndrome 
(2). While this syndrome does not seem to be age specific, it does target by 
gender. Fibromyalgia affects women much more than men in an approximate 
ratio of 20:1 (3). In addition to this, 90% of the patients treated in rheumatology 
practices for fibromyalgia are women (2). 
Symptoms 
Because FM has few symptoms that are outwardly visible, it has been 
nicknamed "the invisible disability" or the "irritable everything" syndrome (4). The 
most common characteristic of fibromyalgia is that of pain. The pain of FM is 
profound, widespread and chronic. It knows no boundaries, migrating to all parts 
of the body and varying in intensity. It has been described as a deep muscular 
aching, throbbing, stabbing and shooting pain that defines the very existence of 
the fibromyalgia patient (3). While this extreme pain is a reality for many FM 
patients, others report a much lower pain intensity that is only a moderate in 
nature. Fatigue is a symptom that is also highly reported as problematic in 78 to 
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94% of FM patients (5). Interestingly, fatigue seems to be more prevalent in FM 
than in other rheumatological conditions. Furthermore, in a study examining 
daily fatigue and pain in FM, fatigue was reported to constitute a greater obstacle 
in the accomplishment of daily tasks than pain (5). 
In addition to pain and fatigue, a number of other symptoms are usually 
reported and associated with FM. Many patients also complain of sleep 
disturbances. Despite sufficient amounts of sleep, patients may awaken feeling 
unrefreshed as well as having difficulty falling asleep or staying asleep (4). 
Another major symptomatic problem of Fibromyalgia seems to be depression. 
Although reports are somewhat unclear on the true numbers affected by 
depression with estimates ranging from 14-76% (5). Typically patients also 
suffer from one or more of the following: body stiffness, increased headaches or 
facial pain, cognitive disorders including spaciness or memory lapses, 
paresthesia (numbness and tingling particularly in the hands and feet), 
myofascial trigger points, chest pain, dysequilibrium, restless leg syndrome (an 
irresistible urge to move the legs particularly when at rest), irritable bowel 
syndrome (includes abdominal pain, bloating, constipation and/or diarrhea), 
increased frequency of urination, hypersensitivity to light, sound, touch, and 
odors, and skin complaints such as itchy, dry, or blotchy skin (2,4). 
Diagnosis 
Despite these numerous symptoms, a physician's diagnosis of FM is 
based on taking a careful history and finding tender pOints in specific areas of 
muscle (3). In 1990, the American College of Rheumatology concluded that 
fibromyalgia could be diagnosed by two specific criteria: a history of widespread 
pain occurring for longer than 3 months in all four quadrants of the body, and 
identified pain in 11 or more of 18 specified bilateral tender points in muscular 
tissue (Figure 1) when approximately four kilograms of pressure was applied 
(2,3,4,6). 
Figure 1: Fibromyalgia Tender Points Identified By 
The American College of Rheumatology in 1990 (4) 
Tender points can occur in muscles, ligaments, or tendons and localize pain 
upon stimulation rather than referring it to an adjacent area as a trigger +point 
would (2). The presence of these many tender points has been correlated with 
depression, fatigue, anxiety, and other somatic symptoms as well as with pain 
(6). These set requirements for a diagnosis of FM provided a sensitivity of 88% 
and a specificity of 81 % in distinguishing FM from other causes of chronic 




Throughout this work, some specific aspects of the endocrine and 
neuroendocrine system will be examined. The body can be affected either 
directly or indirectly by external changes and can only survive if the consistency 
of its environment can be controlled. The endocrine system is one way in which 
the body responds to reoccurring environmental changes. The word "endocrine" 
refers to the internal secretion of biologically active substances, which are 
commonly known as hormones. Hormones are released by endocrine glands 
and transported through the bloodstream to designated tissues. Once there, 
they act by binding to specific receptors on a target cell's surface or within the 
cell, which generally results in a cascade of intracellular reactions and therefore 
amplifies the original stimulus (7). 
Traditionally the endocrine system is distinguished from the nervous 
system because the nervous system is connected to its target tissues through 
neurons that carry and transmit chemical signals (8). This is accomplished 
through neurotransmitters that mediate the synaptic transmission between two 
neurons. These chemical transmitters are synthesized in the cell body and travel 
down an axon where they are stored in synaptic vesicles and released upon 
depolarization. Unlike hormones, neurotransmitters act directly in the target's 
vicinity instead of traveling through the circulatory system and being distributed to 
all tissues. This allows the release of high concentrations of a transmitter to a 
particular target while preventing the release of that transmitter at other locations 
throughout the body (8). It is interesting to note that the same molecule may act 
either as a hormone or as a neurotransmitter depending on where it is being 
released within the body (8). Sometimes both neurotransmitters and hormones 
are secreted by neurons, forming an interaction which is known as the 
neuroendocrine system (7). Both of these systems help maintain the body's 
internal environment and can cause important long-term changes in an 
organism's behavior that mayor may not be beneficial. 
Physiology of the Stress Response 
General Response to Stress 
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As previously mentioned, the body is in a constant struggle to combat 
external changes and maintain homeostasis, or a dynamic steady state. Any 
adverse force that causes a series of reactions that alters the body's 
homeostasis is known as a stressor. When faced with excessive demands, a 
person's adaptive responses take on a stereotypic nature, a state known as 
"stress." More specifically, stress can be defined as a state in which the brain 
interprets the quantity of stimulation to be excessive or the quality of stimulation 
threatening with the brain subsequently responding in a generalized manner (10, 
11). A good understanding of the systems that control the response to stress 
and their physiological consequences is necessary when examining the negative 
impact of stress. 
During stress, attention is enhanced, and the brain focuses on the 
perceived stress. Cardiac output and respiration are enhanced, and blood flow is 
redirected to fuel the aroused brain, heart, and muscles. Furthermore, normal 
endocrine functions such as growth, reproduction, and pleasure are shut down to 
conserve needed energy (11). 
10 
The stress response, which is initiated by both the nervous and endocrine 
systems, is centrally controlled through systems located in the hypothalamus and 
brain stem (9, 12). These control systems include corticotropin-releasing 
hormone (CRH), arginine-vasopressin (AVP) neurons of the hypothalamus, and 
the locus ceruleus-norepinephrine (LC/NE) system (the central sympathetic 
system) (12). The hypothalamic-pituitary-adrenal (HPA) axis and the 
sympathetic system represent the effector limbs by which the brain influences all 
organs in the body throughout the duration of stressful stimuli (11, 12). In 
addition to this, there are interactions of these stress systems with three higher 
brain control areas that influence anticipatory response (mesocortical/mesolimbic 
systems); the initiation, propagation, and termination of stress system activity 
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Figure 2: Hypothalamic-pituitary-adrenal axis (13) 
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The HPA axis 
The HPA axis (Figure 2) is an example of a negative feedback system and 
mainly involves the synthesis and release of three hormones: adrenocorticotropic 
hormone (ACTH), corticotropin releasing hormone (CRH), and cortisol (10). The 
hypothalamus controls the secretion of ACTH from the anterior pituitary, which 
then stimulates the adrenal cortex to release glucocorticoid hormones (11, 12). 
The main glucocorticoid hormone secreted in humans is cortisol (11). An 
excessive amount of this hormone has long been known to mark subjects 
undergoing stress. After intensive research, the factor responsible for 
corticotropin secretion was isolated as a 41 amino acid peptide and named CRH 
(10-12). 
After its release, CRH acts as the main hypothalamic mediator of HPA 
axis activation by regulating ACTH secretion (11, 13). Arginine vasopressin 
(AVP) has little ability to stimulate ACTH secretion on its own, but when 
combined with CRH, the two work synergistically to increase ACTH secretion 
(11-13). CRH and AVP control ACTH production and release through separate 
receptors and signaling pathways, allowing for a very rapid increase in ACTH 
secretion when circulating glucocorticoid levels become too low (10). This is 
made possible through reciprocal positive interaction where each neuropeptide is 
capable of stimulating the other (11). 
Under nonstressful conditions, both CRH and AVP are secreted in a 
circadian (24 hour), pulsing fashion, with about two to three secretatory pulses 
per hour (12). Under resting conditions, the amplitude of these pulses increases 
in the early morning, which results in ACTH and cortisol bursts in the general 
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circulation (12). These are known as diurnal variations and can be disrupted by 
stress (11). During stress, the amplitude and frequency of CRH and AVP pulses 
increase, therefore resulting in a marked increase of ACTH and cortisol 
secretatory bursts (11, 12). 
Glucocorticoids are the final products of the HPA axis and are involved in 
maintaining whole body homeostasis and the response to stress. They assist in 
regulating the basal level of the HPA axis as well as the termination of the stress 
response (12). Through inhibitory negative feedback on ACTH secretion, the 
time that tissues are exposed to glucocorticoids is limited (12). This minimizes 
their catabolic, immunosuppressive, and anti-inflammatory effects, which limits 
the possibility of tissue destruction (14). 
Chronic Stress 
Chronic stress can alter the body's normal response in a different manner 
than acute stress (15). The stress response is intended to be limited in duration 
with an appropriate initiation, amplitude, and termination (11). This limited nature 
of the response renders the effects beneficial rather than damaging (12). In 
contrast, chronic activation of the stress system can lead to a syndromal state 
described by Selye in 1936 (12). 
Chronic HyperlHypoactivation of the Stress System 
Because CRH is involved in almost every area of stress adaptation, the 
magnitude and duration of its production has been evaluated to help explain the 
pathogenesis of many syndromes (12). The best example of chronic 
hyperactivation is seen in melancholic depression. Here cortisol secretion is 
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increased, and ACTH response to CRH is decreased (11, 12). Another strong 
example of an overactive axis is demonstrated in Cushing's disease. This 
disease is characterized by a feedback abnormality, where CRH and ACTH 
secretion are only suppressed at inappropriately high circulating levels of cortisol, 
resulting in hypercortisolaemia (7,8). Chronic hypoarousal, however, is 
characterized by chronically reduced secretion of CRH (12). This state has been 
consistently linked with atypical depression and chronic fatigue syndrome (11, 
12). In this glucocorticoid-deficient state it is believed that the body remains 
relatively resistant to infections but has an increased susceptibility to 
autoimmune/inflammatory diseases (11, 12). While the above descriptions 
involving CRH levels are accurate, a more simplistic understanding of these two 
states is possible. In order to maintain sensitivity to new incoming stressors 
during chronic stress the body has two options: to increase the drive on 
hormone production and release resulting in a hyperfunctioning axis, or to 
become resistant to the effect of circulating glucocorticoids which would result in 
a hypofunctioning axis (14). In either case, the appropriate negative feedback 
within the HPA axis is lost (14). 
Fibromyalgia and Stress 
It has been frequently observed that the onset of FM symptoms occurs 
following a significant stress or period of stress, such as a death in the family or a 
serious illness (13). In addition to this, approximately 65% of patients report that 
the intensity of their symptoms directly correlates with their current stress level 
(16, 22). It is also important to remember that simply living with a syndrome such 
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as FM results in exposure to a chronic stressor. The reported rates of 
depression previously mentioned far exceed the rates in normal healthy 
populations, indicating a high degree of emotional distress as well (22). With this 
information, much of the research over the past decade has concentrated on 
examining the stress response system in fibromyalgia patients. Although some 
of the data and interpretations accumulated by researchers are conflicting, all 
agree that there are abnormalities in the FM patient's neuroendocrine response 
to stress. It is because of this that some researchers have started to consider 
FM as a "stress-related syndrome" (14-18). 
Research Data 
Studies performed by McCain and Tilbe on basal HPA axis function in 
patients with FM demonstrated low 24-hour urine free cortisol levels compared 
with normal subjects (13, 16-19, 21, 24, 25). Patients also showed normal 
morning (peak) and elevated evening (trough) cortisol levels, resulting in the loss 
of normal diurnal cortisol fluctuation. In this flattened diurnal cortisol pattern, the 
elevated cortisol levels could not be suppressed by dexamethasone, a potent 
glucocorticoid that normally suppresses pituitary ACTH and results in a decrease 
of plasma and urine corticosteroids (13,16-19,21,24,25). Furthermore, 
abnormal cortisol levels seem to predominate in patients who have suffered from 
FM for a duration greater than two years (13, 16). All of these results were 
confirmed in a later more expanded study by Ferraccioli et al. It should be noted 
however, that in one study by Adler et al. 24-hour urinary free cortisol, and the 
diurnal pattern were reported as normal (23). 
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In order to determine whether or not this abnormality originated at the 
hypothalamic or pituitary level, Griep et al. injected patients with CRH in the 
morning, when no significant difference in cortisol levels should exist. This test of 
the HPA axis's response to injected CRH is a fairly accurate measurement of its 
stress-induced activation. Results revealed a hyperactive ACTH release with a 
blunted cortisol response relative to the ACTH stimulation (18, 19,24,25). In a 
similar study by Riedel et aI., basal values of ACTH and cortisol were shown to 
be higher prior to the CRH stimulation (19). A more recent study by Griep et al. 
comparing FM patients, patients with low back pain, and controls concluded that 
while pre-stimulation basal levels of ACTH appeared higher, the basal cortisol 
levels were significantly reduced (21). Despite the pre-stimulation discrepanCies, 
both of the previously mentioned studies confirmed that following CRH injection 
only ACTH reached a higher level in FM patients, while no significant changes in 
cortisol concentrations were observed (19, 21). In addition to this, the latter 
study reported that not only was the ACTH response hyperactive in magnitude, it 
was also significantly more prolonged (21). The results of the Griep et al. study 
can be seen in Figure 3. Similar results to the previous studies were also 
confirmed in experimental data by Crofford (13, 16). Furthermore, Crofford 
observed low cortisol levels following exercise and an increase release of AVP, 
with five of the twelve patients achieving AVP levels more than two standard 
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Figure 3: Response of ACTH and cortisol to patients with FM (closed circle), 
with low back pain (closed square), and healthy controls (open circle); arrow 
indicates the time of injection (20). 
Discussion of Data 
The results demonstrating low 24-hour urine free cortisol, which reflects 
the time-integrated plasma free cortisol concentrations over 24 hours, seem 
incongruent with the corresponding occurrence of higher cortisol levels in the 
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evening but normal morning levels. A plausible explanation provided by Crofford 
hinges on the pulsing nature of cortisol secretion. There are normally eight to 
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nine peaks of cortisol over a 24-hour period, with the highest secretion occurring 
during the nighttime (8). These theoretically should be in response to basal 
surges of CRH and ACTH. It is possible that in FM, the height of the cortisol 
peaks might be normal or elevated, but the frequency of the peaks could be 
decreased, resulting in a low cortisol output over a 24 hour period (13, 16, 18, 
24). 
The results of the experiments involving CRH become much more difficult 
to explain. Although many researchers found similar data, there have been 
several different interpretations concerning the implications of those results. 
Earlier studies by Crofford et al. explain the blunted cortisol response to ACTH 
release as the result of a hyporesponsive adrenal gland due to hypoactivity of the 
adrenal cortex or through chronic understimulation from deficiencies of CRH or 
ACTH (13,16). This interpretation has been linked to similar findings in patients 
with CFS, as both syndromes are permeated by fatigue (13). Interestingly, in 
Crofford's latest published work the conclusion made from the same data is 
characterized by a hyperactivity of the stress system, instead of the previously 
mentioned hypo responsive system. In this work Crofford correlates the results to 
comparable findings in patients with depression or Cushing's syndrome (18). 
Similarly, Neeck interprets the data as a hyperfunctioning system resulting as an 
adaptive mechanism of a chronically stimulated adrenal cortex with a decrease in 
receptor regulation (19). In Griep's most recent study he explains the results as 
the apparent hyporesponsiveness of cortisol secretion to increased ACTH 
stimulation, which is known as hypocortisolemia (21). This is in direct conflict 
with Crofford's correlation of FM to Cushing's syndrome, which is characterized 
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by hypercortisolaemia (8). In addition to this Griep also states that the HPA 
activity in FM is clearly different from that of depression, which is characterized 
by a hyperactivity of all parts of the HPA axis (21). He argues that in depression 
the feedback abnormality is found at the corticosteroid level, while it is more 
probable that in FM the feedback resistance exists at the glucocorticoid level 
(21). This conclusion is based on his findings that the ACTH response to CRH is 
more prolonged, suggesting a defect in cortisol control. This impaired feedback 
may be a result of glucocorticoid receptor function, instead of the adrenal 
receptor function suggested by Neeck (21). 
The Link Between Stress and Pain 
Two of the major systems affected by fibromyalgia are the stress-
regulating system and the nociceptive system. While the stress response has 
been extensively reviewed thus far, the primary complaint of these patients is still 
pain related. There are generally two types of pain described by FM patients: 
Allodynia, pain from normally non-painful stimuli and Hyperalgesia, an increase 
in pain intensity and prolonged pain duration from normally painful stimuli (27). 
In accordance with this, studies have shown that pain thresholds in these 
patients are two to three times lower than the levels in healthy controls (25). 
Recently many researchers have concluded that the origin of fibromyalgia 
exists within abnormal processing of the Central Nervous System (20, 25, 27, 
28). Proponents of this theory believe that the long-standing excitation of 
nociceptors may initiate and maintain a constant hyper-excitability in pain 
response (27). These same researchers believe that abnormalities seen in the 
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stress response system result only from chronic pain. It is believed that since 
pain is both a chronic and emotional stressor, it exists as the sole trigger of 
hormonal abnormalities. At the same time, there are those that still believe that 
the primary cause of FM symptoms is a result of other stressors, which in turn 
trigger abnormal pain behavior to perpetuate the cycle (13, 16, 17). 
General Interactions 
Regardless of whether or not stress or pain is the initial activating factor, 
these two systems are intertwined through a myriad of various feedback loops. 
Their interaction exists on such a level in which the alteration of one system will 
inevitably have some effect on the components of the other. This is 
demonstrated by the fact that a temporary increase in pain and allodynia is 
almost always correlated to an increase in the patient's stress level (27). 
Additionally, patients who score higher on all pain scales also score higher on 
tests for anxiety, depression, and general distress (28). It is also interesting to 
note that some of the most successful treatments of pain involve a reduction in 
stress. Patients who are most successful in lowering their pain levels have at 
least one of three characteristics in common: a high level of self-efficacy (the 
belief in one's ability to engage in actions sufficient to attain a desired health 
outcome), a belief that they personally posses the ability to control and decrease 
their pain, and a frequent use of adaptive coping strategies and support groups 
(25). Each of these characteristics demonstrates an obvious and direct reduction 
in personal stress. 
Specific Interactions 
It has been proposed that CRH may be the crucial link between the pain 
and stress responses. CRH activity may determine not only the symptoms of 
FM, but may also be the cause of many hormonal deviations previously 
discussed. Since altered levels of CRH have been observed in situations that 
are initiated and driven by either pain or stress, it is possible that this hormone 
plays a role in resetting endocrine and nociceptive mechanisms (20). 
The influence of pain response on the stress system 
The pain response system has a direct effect on the HPA axis by 
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changing CRH levels. The change in CRH levels has been linked to two specific 
factors: Neuropeptide Y (NPY) and Serotonin (5-HT) (16, 19, 20). NPY co-
localizes with norepinephrine and its levels represent sympathetic adrenal output 
(13). In FM patients, plasma NPY levels are much lower than controls (16). This 
is significant since the presence of NPY has been reported to increase 
concentrations of CRH (16). 5-HT plays an important role in the pain response 
system since one of its functions is to block the brain's perception of painful 
stimuli. Studies have found significantly lower serum levels of 5-HT in FM 
patients (19, 20). As would be expected, a highly inverse relationship was found 
between 5-HT levels and the intensity of perceived musculoskeletal pain (20). It 
is possible that low 5-HT levels may decrease anti nociceptive mechanisms within 
the spinal cord, explaining allodynia in FM patients. In addition to this, 5-HT is 
linked to the regulation of the HPA axis through CRH. CRH containing neurons 
receive synaptic input from 5-HT neurons, which is one of the mechanisms by 
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which CRH is released (19). Here an abnormality in pain processing influences 
the stress response system to also respond in an irregular manner. 
The influence of stress response on pain perception 
In other mechanisms, altered levels of CRH may result in increased pain 
perception. As chronic stress persists, there seems to be a loss of negative 
feedback as previously discussed. As CRH levels increase, the release of 
somatostatin occurs, which serves to inhibit the release of growth hormone (GH) 
and insulin-like growth factor (IGF-I) (19). Studies have shown that both GH and 
IGF-I have low 24-hour levels in FM patients (14). Some have speculated that 
impaired GH secretion may disturb normal muscle homeostasis and therefore 
induce muscular pain (20). Additionally, it has been shown that decreased levels 
of IGF-I are associated with lower pain thresholds. In a study on rats, 
administration of IGF-I resulted in an increase in nociceptive threshold, and 
chronic administration resulted in a halted progression of hyperalgesia (14). 
As levels of CRH rise there tends to be a blunted response of 
glucocorticoids in FM patients as previously discussed. Since glucocorticoids 
serve as powerful anti-inflammatory agents, a decreased response should 
theoretically result in increased inflammation. Interestingly, pain researchers 
have found that hyperalgesia can result from increased inflammation with a result 
almost identical to persistent pain conditions (25). Following inflammation, 
nociceptive neurons often have an increased excitability and an increased 
response to mechanical, thermal, and chemical stimuli. This hyperexcitability 
leads to increased activity at higher brain centers and is perceived as more 
intense and prolonged pain as seen in Figure 4 (14, 25). This possible 
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mechanism could serve to explain both the allodynia and hyperalgesia exhibited 
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Figure 4: (a) Under normal conditions, low frequency activation of nociceptors 
by mild noxious stimuli results in an appropriate pain response. Activation of 
non-noxious mechanoreceptors also results in a response but at a level 
insufficient to initiate a pain response. (b) Following increased inflammation, the 
same noxious stimulus is correlated with persistent noxious input to the brain. 
There is also recruitment of the previously silent synapse and the activation of 
the mechanoreceptors is now sufficient to result in a pain response (14). 
A Predisposition for Fibromyalgia 
Due to the nature of this syndrome and the possible neuroendocrine 
involvement in its pathogenesis, it seems highly probable that fibromyalgia 
patients have some sort of vulnerability to the onset and continuation of 
symptoms. Additional support for this idea exists, as FM has been shown to 
have a high occurrence in more than one member of a family (27). Genetic and 
environmental factors work together throughout development to shape the 
specific phenotype of an individual. Therefore the HPA axis is variable among 
individuals and can be determined by a number of different factors (13). 
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The importance of genetic variability has been demonstrated in studies of 
various rat strains. For example, Lewis rats have been shown to have a blunted 
HPA axis response when exposed to a variety of stressors, while Fischer rats 
display an exaggerated HPA axis response when exposed to the same stressors 
(17,22). Lewis rats also show differences in levels of CRH and AVP peptide 
hormones as well as receptors for serotonin (26). In addition to this, these 
various strains also demonstrate differences in diseased susceptibility, vigilance, 
exploration, and apparent fear, which may all be related to differences in the 
central components of the HPA axis (17). 
In another study, the importance of neonatal environmental factors was 
observed. Here male Long Evans rats were exposed to either repeated pain or 
maternal separation in the first two weeks of life (25). After exposure, the rats 
demonstrated enhanced central neurocircuit activity and HPA axis 
responsiveness as well as extreme anxiety and a reactivity of the dopaminergic 
system (24, 25). These alterations were perpetuated into adulthood where HPA 
axis function, central gene expression, and pain threshold abnormalities were 
exhibited (25). This study suggests that adverse early experiences, such as 
neglect or abuse, can significantly modify the body's response to major stressors 
encountered later in life. 
These studies give some insight into a possible origin of fibromyalgia, 
which otherwise seems to have an unexplainable onset. It is therefore possible 
that genetics and experience may contribute to a vulnerability of stress-related 
syndromes that have classic physical and psychological symptomology. 
However, the specific mechanisms by which a proceeding acute stress is 
translated into a syndrome of chronic pain still remain to be determined. 
Future Research and Conclusion 
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Despite the various interpretations of data previously stated, it is obvious 
that neuroendocrine abnormalities do exist throughout the HPA axis. Whether 
the result is of a hyper or a hypo functioning stress response, there is agreement 
that negative feedback systems are impaired. More progress may be made 
when researchers cease trying to categorize FM under broad categories like the 
hyper/hypo functioning HPA axis, therefore linking it to other disorders. It seems 
clear that FM is not identical to any other syndrome or illness and therefore 
should not be similarly categorized. By viewing this syndrome as its own distinct 
entity, more options may present themselves concerning the syndrome's 
etiology. 
Those who have started to view FM as a disorder of pain processing in the 
Central Nervous System have been able to examine the syndrome without 
consistently linking it to other disorders. However, much of the research in this 
field blatantly ignores pertinent research on stress induced neuroendocrine 
abnormalities. In 1997 a small conference workshop was held inviting experts in 
the fields of pain and neuroendocrine function in FM patients. After sharing their 
acquired knowledge, a combined work was written concluding that the integration 
of neuroendocrine and pain research was imperative to the future research and 
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understanding of FM (24). Unfortunately, to this date no such work can be found 
linking these two most pursued research fields. It is highly probable that the 
etiology of the syndrome will not be discovered until an interdisciplinary approach 
is taken, and the interactions of these systems are fully examined. 
Specifically, more research is needed on the psychosocial factors involved 
in pain vulnerability and expression, which may demonstrate a genetic 
predisposition to chronic pain conditions. This possibility could help prove the 
theory that the syndrome originates as a pain disorder, which is perpetuated by 
the stress of pain. Similarly, those supporting the stress origin need to 
investigate a way to distinguish neuroendocrine vulnerability leading to the 
development of FM from abnormalities that might result from the syndrome. 
Since many studies are done on patients who have been ill for several years, it is 
difficult to know whether or not the observed abnormalities in the HPA axis 
represent a pre-existing, intrinsic defect, or if the abnormalities are acquired as a 
result of FM symptoms. 
Finally, in FM research there seems to be a pervasiveness of inconsistent 
findings. A possible explanation and direction for future research has been 
proposed involving the groups of patients being examined. It could be that while 
researchers tend to view FM as if it was comprised of a homogeneous set of 
patients, a more heterogeneous approach should be taken (22). Although many 
symptoms are common, FM patients seem to be a group with diverse 
characteristics and responses. In order to better understand the syndrome, it 
might be profitable to look for commonalities that would divide FM patients into 
multiple subgroups under a larger diagnosis. 
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